Countries
Industry
Startup stage
Startup size
Funding
Impact startup SDGs
Showing: 11293 filtered startups

Vibelabs

We're builders who love teaching what we do. Vibelabs helps everyone become builders, teaching people with no coding experience how to build software and tools with AI. Nearly 1,000 people have gone through our programs, including teams from Telenor, OBOS, Mesta, and other leading Norwegian organizations. We partner with StartupLab to bring AI skills to corporate innovators and early-stage founders. But we don't just teach, we build. We launch our own ventures, and help founders, operators, and small teams turn ideas into real, scalable products. Combining AI-native workflows, rapid prototyping, and modern product thinking, we move fast without cutting corners. From early MVPs to production-ready platforms, we focus on execution, clarity, and momentum. The barrier to building software just dropped to near zero. Companies that get this will move faster. People who get this will have a massive edge. We're here to make sure as many as possible get there, practically, not theoretically.

Hive Brazilian Jiu Jitsu

Hive Brazilian Jiu Jitsu is a premium BJJ gym in Copenhagen built on two things: world-class instruction and a community that takes the sport seriously without taking itself too seriously. We train kids, adults, and a fast-growing group of women who are finding their footing — and confidence — on the mat. Our members come from all over the world, which means Hive is as international as the city it sits in. We've grown through reputation and word-of-mouth, and we're now building the brand infrastructure to match the quality of what happens inside the gym. If you're looking to work on something with a real identity, a real community, and real room to make your mark — this is it.

Heibjerg ApS

Heibjerg is a Danish robotics startup developing autonomous, chemical-free robots for pavement and outdoor area maintenance. Our core product is an autonomous weeding robot that operates in complex environments such as cemeteries, housing associations, and parks. The robot combines advanced navigation, sensor fusion, and AI-based vision to reduce manual labour and environmental impact.

Celto

Celto gør det nemt for mennesker at forstå, følge og påvirke deres sundhed. I dag giver vi adgang til selvvalgte blodprøver med en grundig lægefaglig vurdering og personlig indsigt samlet på én digital platform. Vi blev startet ud fra en frustration over, hvor svært det kan være at få indsigt i sin egen krop. Vores overbevisning er enkel: Du skal ikke være sundhedsekspert for at være en aktiv deltager i din egen sundhed. Blodprøver er begyndelsen. Vores vision er en verden, hvor enhver kan få løbende, personlig sundhedsindsigt og bruge den til at træffe bedre beslutninger. Vi vil bygge systemet, der samler relevante tests, undersøgelser og sundhedsdata, gør dem forståelige og hjælper den enkelte med at prioritere næste skridt og følge, om det virker. Teknologi skal gøre klinisk kvalitet skalerbar, mens det kliniske ansvar bliver hos kvalificerede sundhedsfaglige. Ambitionen er at skalere Celto som et B2C-brand på tværs af Europa og blive den største aktør i vores kategori. Vi lancerede i oktober 2025. Et år senere er vi seks medarbejdere og har haft omkring 30 % vækst om måneden gennem de seneste 12 måneder. Vi er stadig tidligt i rejsen, og du kan få reel indflydelse på både produktet og virksomheden. Fra 1. november 2026 holder vi til i et penthousekontor på Kronprinsensgade 1, midt i København. Vi bygger et hold af A-players. Mennesker, der tager ansvar, lærer hurtigt, stiller høje krav til sig selv og gør dem omkring sig bedre. Vi accepterer ikke, at en lav indsats eller en dårlig indstilling trækker resten af holdet ned. Arbejdsmoral, ambitionsniveau og talent vejer tungere end et langt CV og en uddannelse. Fem af os er 24 år, og vi vil være blandt de dygtigste i Danmark i vores generation. Du behøver ikke have samme alder. Du skal have lyst til at sparke røv sammen med os. Hos os møder alle ind. Vi bygger virksomheden sammen, og det kræver, at vi er samme sted. Vi arbejder hårdt, stiller høje krav til hinanden og har det fedt undervejs. Midt på dagen træner vi eller dyrker anden sport sammen, spiser frokost og går tilbage til arbejdet med ny energi. Vi kommer til at bruge mange timer sammen, så det betyder noget, at vi både kan udfordre hinanden, grine sammen og løfte i flok. Tempoet er højt, og ambitionerne kræver en stor indsats. Det skal du have lyst til at være en del af. Vi er AI-native ind til benet. AI er en del af, hvordan vi tænker, bygger og arbejder hver dag. Du er enten allerede godt inde i det eller klar til en stejl læringskurve. Vi bygger først og fremmest systemer, der kan skalere. Når vi gør noget manuelt og uskalerbart, er det for at lære noget, vi kan bruge til at bygge et bedre system. Til gengæld får du ansvar, dygtige kolleger og mulighed for at lære helt utroligt meget – også om, hvor meget du selv kan flytte, når du arbejder fokuseret og hårdt. Vi vil gerne se dig vokse i organisationen og bygge dit drømmejob her. Hvis nogle år i Celto bliver springbrættet til dit næste drømmejob, er det også noget vi vil være stolte af. Men vi kommer til at gøre os umage for, at du finder det hos os. Det er et plus, hvis sundhed interesserer dig.

Amass

Amass is an AI application platform for scientific intelligence. Scientific knowledge is scattered, siloed, slow and expensive to search. Amass integrates across this fragmented landscape; Patents, papers, regulatory filings, proprietary documents and data and applies AI to create a structured, cross-linked, and queryable knowledge graph. We build our own domain-specific embedding models to capture subtle scientific signals. We go beyond simple retrieval and enable users to triangulate across multiple sources and trace the evidence behind any output. Who it’s for: biotech and pharma R&D, food-bio and synbio, research institutetes, hospitals, and life-science investors/BD. Why it wins: higher recall across sources, transparent reasoning, and end-to-end automated workflows that turn messy data into decisions and team actions -> quickly and safely. ‍

Sunny Life Co.

Sunny Life is a Copenhagen-based startup shaking up the spread game with sunflower seed butters in flavors you won’t find anywhere else. Most spreads are boring, processed, or nut-only — we’re here to make them fun, nutritious, and inclusive without losing sight of ethics or taste. Everything is made in small batches, with a sustainable, allergen-friendly base and a Scandinavian twist. As a small but growing team, you’ll work closely with the founder and get a behind-the-scenes look at how a business is built from the ground up. It’s hands-on, fast-moving, and a chance to make a real impact (plus free seed butter 🌻).

Vibrant

Payments today are fragmented, rigid, and impersonal. Merchants deserve simplicity, speed, and intelligence. We exist to free merchants from complexity and turn payments into a growth engine — by empowering ISVs as the true distribution channel. We build unified payments for companies. We are app. 20 employees based in Aarhus and Copenhagen.

FEESH

FEESH...the feed for your fish Aquaculture is the fastest-growing food sector and is vital for meeting the protein needs of a growing global population. Yet, its growth is constrained by reliance on two unsustainable protein sources: fishmeal and soy protein concentrate (SPC). Fishmeal is produced from wild-caught fish, putting pressure on already fragile marine ecosystems, while soy production drives large-scale deforestation and carries a heavy carbon footprint. Both are also subject to volatile global markets, making aquafeed production environmentally damaging, expensive, and vulnerable. Insects, particularly Black Soldier Fly Larvae (BSFL), are an attractive and more sustainable alternative. They can be produced locally, upcycle organic waste streams into valuable protein, and have a low environmental footprint. However, despite this potential, insect meal remains a niche ingredient in aquafeeds. The main barrier is chitin, a fiber-like polymer in the insect exoskeleton that reduces digestibility and locks away valuable proteins. This limits inclusion rates of BSFL meal in aquafeeds to just 2–8%, far below the levels needed to meaningfully replace fishmeal and soy. At FEESH, we are solving this problem by applying a precision microbial fermentation platform, enhanced with ultrasonication pre-treatment, to upgrade BSFL meal into a high-performance protein ingredient. Our process disrupts the chitin-protein matrix, making proteins more bioavailable, reducing indigestible fiber, and enriching the lipid fraction with beneficial fatty acids such as EPA and DHA. Additionally, fermentation produces bioactive peptides and immunostimulatory compounds that improve gut health and disease resilience in fish. The result is a fermented insect meal with digestibility levels reaching 90–95%, enabling high inclusion rates of >20% in aquafeeds without compromising fish growth, palatability, or welfare. By combining biological and physical processing, FEESH unlocks the true nutritional potential of insects, transforming them from a niche supplement into a viable replacement for fishmeal and soy protein concentrate. This matters because the aquafeed industry needs scalable, circular, and climate-friendly solutions. Our innovation reduces dependence on environmentally destructive feed sources, cuts CO₂ emissions, and strengthens food system resilience. For insect producers, it creates new market opportunities with higher-value products. For aquafeed formulators and fish farmers, it delivers a sustainable, locally produced protein that supports both performance and animal health. And for society, it contributes to global food security and a more sustainable bioeconomy. FEESH is pioneering the next generation of aquafeed ingredients, designed not just to sustain aquaculture, but to make it thrive responsibly.

Mads Lynderup

Jeg driver webbureauet Mads Lynderup, hvor jeg laver skræddersyede hjemmesider til små servicevirksomheder. Jeg fokuserer på en enkel og gennemsigtig proces uden skjulte gebyrer eller bindinger, og mine kunder ejer altid deres hjemmeside 100%. Mit mål er at ændre den måde markedet fungerer på i dag, hvor store webbureauer fyldt med supersælgere ofte tager røven på mindre virksomheder og sælger dem ting, de ikke har brug for. Jeg skaber i stedet professionelle og funktionelle hjemmesider, der giver synlighed og nye kunder – hurtigt og uden stress.

The Thea Company AB

It all started during a long and warm trip through Southeast Asia, inspired by the rich varieties of tea and the rich culture behind them. Back home in Sweden, the shelves were full of sugary ice teas, mostly peach or lemon, accompanied by kombucha that, while being healthy, is not everyone’s cup of tea. Then Théa was born: A non alcoholic sparkling tea drink that tastes amazing, made of real tea leaves, refreshing, full of natural tea benefits and no added sugars.

GLAZE Technologies

GLAZE Technologies turns raw data into “material intelligence.” Across energy, aerospace, and manufacturing, critical components can fail because decision-makers can’t see what’s happening inside their materials until it’s too late. Today they must choose between expensive lab testing or flying blind on the factory floor. We solve that gap with Carmen, our patented, real-time sensor platform that reveals a material’s composition, defects, and degradation at industrial speed and scale. Powered by breakthrough terahertz technology, Carmen spots micro-cracks in wind-turbine blades before they splinter, verifies satellite parts for the European Space Agency, and will soon help any production line certify quality without stopping the line. Why does it matter? Because better material insight means safer infrastructure, fewer recalls, less waste, and a faster transition to a sustainable, high-performance world. We’ve proven the tech in pilots with global consortia; now we’re scaling the business. and looking for bold minds to join the journey.

Sophie AS

Sophie helps small property owners stay in control of building maintenance without any strain. Our solution requires no need of industry knowledge and detailed expertise related to the laws and regulations of commercial property management. Incidents related to building portfolios are seldom caused by bad intentions of the landlord, but occurs due to lack of proper systems in place to ensure compliance and care. The market for smaller landlords cross border is vast due to a big market gap and due to existing vendor's failure to serve this group properly. The laws and regulations related to real estate is extensive. Current systems on the market are expensive, difficult to use and timely to implement. Sophie is a self-served autonomous solution which simplifies tasks and removes the need for backoffice functions through AI and low-code, making it cost efficient and easily accessible for smaller property managers. The team behind Sophie has long industry experience from commercial property management, SaaS, proptech and scaling companies.

Trustyou

The problem we address is the growing struggle parents face in managing their children's digital well-being. Kids today are exposed to excessive screen time, social media pressures, and online risks, yet most existing parental controls focus on restrictions rather than guiding healthy digital habits. Why this problem is pressing: Mental Health Risks: Increased screen time and unmonitored online activity contribute to anxiety, depression, and sleep issues in children. Ineffective Tools: Most parental controls rely on blocking and monitoring, leading to conflicts and workarounds rather than fostering responsible digital use. Parental Overwhelm: Parents lack the time and knowledge to constantly monitor and guide their child’s digital habits effectively.

Comeply ApS

Comeply is a pioneering SaaS compliance management platform designed specifically for organizations navigating the complex regulatory landscapes of highly regulated industries, with particular expertise in pharmaceutical compliance. We transform how companies understand, monitor, and maintain their compliance posture by delivering real-time regulatory intelligence coupled with powerful analytical capabilities. Our platform continuously scans, processes, and interprets regulatory changes from authoritative sources including ICH, FDA, EMA, eCFR, and pharmacopoeias, creating an always-current compliance knowledge base. What sets Comeply apart is our unique ability to automatically compare regulatory requirements against a company's internal quality management documentation, identifying compliance gaps and potential risk areas before they become issues. We provide dynamic compliance scoring that quantifies and visualizes compliance status across various regulatory domains such as safety, site oversight, and quality management, enabling leadership to make informed decisions based on clear compliance metrics. When regulations evolve, our sophisticated delta analysis highlights specific differences between previous and updated requirements, with targeted notifications that connect directly to the departments and processes affected within your organization. Beyond mere notification, Comeply delivers contextual understanding of regulatory changes, showing precisely how they impact your current compliance position and what actions may be required. By automating the labor-intensive processes of regulatory monitoring and interpretation, we enable compliance and quality assurance teams to shift from reactive document management to strategic compliance leadership, reducing compliance risk while simultaneously cutting monitoring costs by up to 80%. For pharmaceutical companies and other organizations where regulatory excellence is non-negotiable, Comeply transforms compliance from an operational burden into a sustainable competitive advantage.

Gefjon Pharma ApS

Gefjon Pharma ApS has developed a groundbreaking platform technology based on our unique hyper vesiculating outer membrane vesicle (OMV) technology. This combined with our unique extraction method enable high-yield cost-effective production of bio-industrials and therapeutics. ​ Our first product is a revolutionary broad-protective bacterial E. coli vaccine targeting poultry production. We have PoC for both the vaccine and an aerosol application method. ​ With E. coli being the single most important cause of mortality and infections in poultry, we will significantly reduce global consumption of antimicrobials, thereby minimizing the development of antimicrobial resistance (AMR), improve animal welfare, and reduce CO2 emissions and food waste, while increasing customer profits. ​ With our excellent customer relations and a strong demand for new vaccines, market entry barriers are low, and the potential is massive. ​ Vision: Saving lives through our platform technology, making cost-effective therapeutics available for everyone & everywhere​